【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 17
2 Introduction 18
2.1 Acquired Gene or Chromosome Alterations Overview 18
3 Products under Development 19
3.1 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 19
3.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Territory 20
3.3 Acquired Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 21
3.4 Acquired Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 22
4 Acquired Gene or Chromosome Alterations – Pipeline Products under Development by Companies 23
4.1 Acquired Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 23
4.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 26
5 Acquired Gene or Chromosome Alterations Companies and Product Overview 36
5.1 Abbott Diagnostics Company Overview 36
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 Agendia NV Company Overview 177
5.2.1 Agendia NV Pipeline Products & Ongoing Clinical Trials Overview 177
5.3 AltheaDx, Inc. Company Overview 178
5.3.1 AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 178
5.4 Amarantus Bioscience Holdings, Inc. Company Overview 181
5.4.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.5 AstraZeneca Plc Company Overview 183
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 183
5.6 AutoGenomics, Inc. Company Overview 185
5.6.1 AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.7 Biocept, Inc. Company Overview 186
5.7.1 Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.8 Cepheid Company Overview 189
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 189
5.9 Chinese University of Hong Kong Company Overview 192
5.9.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 192
5.10 Columbia University Company Overview 194
5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 194
5.11 Dana-Farber Cancer Institute, Inc. Company Overview 195
5.11.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.12 DiaCarta Company Overview 196
5.12.1 DiaCarta Pipeline Products & Ongoing Clinical Trials Overview 196
5.13 Exosome Diagnostics, Inc. Company Overview 197
5.13.1 Exosome Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.14 Gencurix Co., Ltd. Company Overview 198
5.14.1 Gencurix Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
5.15 GeneFirst Ltd Company Overview 199
5.15.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.16 GenMark Diagnostics, Inc. Company Overview 203
5.16.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.17 Genomic Health, Inc. Company Overview 205
5.17.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.18 Genomic Vision Company Overview 207
5.18.1 Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview 207
5.19 GenomicTree, Inc. Company Overview 210
5.19.1 GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210
5.20 German Cancer Research Center Company Overview 212
5.20.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 212
5.21 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 214
5.21.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214
5.22 Harvard University Company Overview 216
5.22.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 216
5.23 Helmholtz Centre for Infection Research Company Overview 217
5.23.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 217
5.24 HistoRx, Inc. (Inactive) Company Overview 218
5.24.1 HistoRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 218
5.25 Illumina, Inc. Company Overview 220
5.25.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220
5.26 Insight Genetics, Inc. Company Overview 223
5.26.1 Insight Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 223
5.27 InVivoScribe Technologies, Inc. Company Overview 225
5.27.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 225
5.28 Med BioGene Inc. Company Overview 226
5.28.1 Med BioGene Inc. Pipeline Products & Ongoing Clinical Trials Overview 226
5.29 Merrimack Pharmaceuticals, Inc. Company Overview 227
5.29.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 227
5.30 MolecularMD, Corp. Company Overview 229
5.30.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 229
5.31 Multiplicom N.V. Company Overview 230
5.31.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 230
5.32 Myriad Genetics, Inc. Company Overview 231
5.32.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
5.33 Nanosphere, Inc. Company Overview 234
5.33.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 234
5.34 New York University Company Overview 237
5.34.1 New York University Pipeline Products & Ongoing Clinical Trials Overview 237
5.35 NIH Office of Technology Transfer Company Overview 238
5.35.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 238
5.36 Oryzon Genomics S.A. Company Overview 240
5.36.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 240
5.37 Oxford Biodynamics Limited Company Overview 241
5.37.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 241
5.38 Panagene Inc. Company Overview 246
5.38.1 Panagene Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
5.39 Pangaea Biotech, S.L. Company Overview 250
5.39.1 Pangaea Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 250
5.40 PDI, lnc. Company Overview 254
5.40.1 PDI, lnc. Pipeline Products & Ongoing Clinical Trials Overview 254
5.41 PharmaSeq, Inc. Company Overview 256
5.41.1 PharmaSeq, Inc. Pipeline Products & Ongoing Clinical Trials Overview 256
5.42 Qiagen N.V. Company Overview 258
5.42.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 258
5.43 RedPath Integrated Pathology, Inc. Company Overview 268
5.43.1 RedPath Integrated Pathology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 268
5.44 Response Genetics, Inc. Company Overview 269
5.44.1 Response Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 269
5.45 Rheonix, Inc. Company Overview 272
5.45.1 Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 272
5.46 Seegene, Inc. Company Overview 274
5.46.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 274
5.47 Shuwen Biotech Co. Ltd. Company Overview 276
5.47.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 276
5.48 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 284
5.48.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 284
5.49 Sygnis AG Company Overview 288
5.49.1 Sygnis AG Pipeline Products & Ongoing Clinical Trials Overview 288
5.50 Sysmex Corporation Company Overview 290
5.50.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 290
5.51 The Johns Hopkins University Company Overview 292
5.51.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 292
5.52 thromboDx Company Overview 294
5.52.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 294
5.53 Transbiomed, SL Company Overview 296
5.53.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 296
5.54 Transgenomic, Inc. Company Overview 297
5.54.1 Transgenomic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 297
5.55 TrovaGene, Inc. Company Overview 299
5.55.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 299
5.56 University of California, Irvine Company Overview 301
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 301
5.57 Vela Diagnostics Company Overview 302
5.57.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 302
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview 307
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
6 Acquired Gene or Chromosome Alterations- Recent Developments 311
7 Appendix 345
7.1 Methodology 345
7.2 About GlobalData 347
7.3 Contact Us 348
7.4 Disclaimer 348
【レポート販売概要】
■ タイトル：世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015■ 英文：Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0077EPD
■ 調査対象地域：グローバル
- 世界のアイスクリーム市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global ice cream market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global ice cream market on a monthly basis. Scope The report provides a review of the latest news and key events in the global ic …
- 大量輸送交通機関セキュリティの世界市場2017-2021About Mass Transit Security Systems Mass transit security systems refer to the security systems used in mass transit locations to detect, monitor, and scan travelers and their belongings. Road, rail, air, and sea transportation systems are designed for easy accessibility and convenience of travelers. Due to the growing number of crime and terror attacks on mass transit systems, governments have ta …
- 世界の熱電対市場2015The Global Thermocouples Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Thermocouples industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Thermocouples market analysis is provided for the international markets including development trends, competit …
- 世界の脊椎インプラント（医療デバイス）市場：融合/非融合インプラントAbout Spinal Implants Spinal implants are devices that help preserve and restore the functions of the spine by managing spinal disorders. Spinal disorders can be degenerative, deformities, trauma, and tumors. Some of the spinal disorders are spondylolisthesis, scoliosis, disc herniation, and spinal stenosis. Spinal implants are composed of metals such as titanium, titanium-alloy, and stainless ste …
- 治験製品サプライ及び物流の世界市場2015-2019About Clinical Trial and Supply Logistics Clinical trial companies, also known as contact manufactures or CROs, offer development and research, and manufacturing services on a contract basis to pharmaceutical and biotechnology vendors as well as government institutions, foundations, and universities. The clinical trial industry uses outbound logistics for the complete management of the way resourc …
- 世界の産業用イーサネット市場動向（2014-2018）TechNavio’s analysts forecast the Global Industrial Ethernet market will grow at a CAGR of 9.85 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to reduce capital and operational expenditure. The Global Industrial Ethernet market has also been witnessing the introduction of cost-effective Ethernet devices. However, the increase in points of f …
- 血管内超音波検査(IVUS)装置（医療機器）のグローバル市場（2012-2018）Global Intravascular Ultrasound (IVUS) sector is projected to reach US$618 million by 2016. The North America accounts for nearly 33% (2015) of the global share while Europe claims approximately 17% (2018). Asia-Pacific is the fastest growing region with a CAGR of 10.3% driving a market value of US$252 million by 2015. Among the product types, IVUS Catheters accounts nearly half of the market valu …
- Candax Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Candax Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Candax Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- ビタミンD検査の世界市場2015-2019About Vitamin D Testing Vitamin D is a naturally occurring, fat-soluble, biologically inert hormone precursor that exists in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Its main biologic function is to maintain calcium and phosphorus concentrations as it is essential for the overall bone health. Vitamin D has a number of other physiological roles, including ret …
- 世界における炭素繊維強化プラスチック(CFRP)企業の上位16社分析：航空、自動車、エネルギー、建設、スポーツ用品用途The carbon fibre composites market will exhibit strong growth in the near future across many industry sectors and applications. Carbon fibre composites are a highly competitive market with a myriad of companies competing for market share in what is a highly fragmented market with no company having a dominant position. The biggest players in the carbon fibre composites market, overall, include Hexc …
- ビデオゲームの世界市場動向Our new study focuses on all market segments of the video game industry impacted by the dematerialisation of distribution, specifically: home and handheld consoles, PCs (including laptops), mobile devices (smartphones, phablets & tablets) and TV sets. This report aims to measure the degree of dematerialisation affecting distribution in each of the market segments above, independently of the techno …
- ハイブリッドクラウドの世界市場2015-2019About hybrid cloud Hybrid cloud is a combination of on-premises, public, and private cloud computing, where applications can switch between private and public cloud depending on the workload. Enterprises are increasingly using the hybrid cloud model, as critical applications can be hosted more securely on private clouds compared to public cloud. Hybrid cloud computing helps enterprises achieve max …
- スマートグリッド市場レビュー：October 2013Smart Grid Review - October 2013 Summary GlobalData announces the release of its monthly smart grid newsletter for October 2013 from the Smart Grid eTrack. The newsletter provides update on the global developments related to smart grid deployment across the globe during the month of September 2013. Scope - Market prospect for companies providing smart grid systems_x000D_ - Key product launch in po …
- 世界のホウ素市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of boron, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing boron production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: boron production in …
- 運動維持手術の世界市場：人工椎間板、人工腰椎板、椎間スペーサーAbout Motion Preservation Surgery Motion preservation surgery helps preserve the motion of the disc space and is an alternative to fusion techniques such as plates and screws or bone grafts, whichrestrict motion. Artificial discs reduce degeneration of adjacent segments of the cervical spine and lumbar, maintain normal neck motion, and ensure faster return to normal activity. Motion preservation i …
